Historial de carrera de Andrea Grant
Antiguos cargos conocidos de Andrea Grant.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| ALGORAE PHARMACEUTICALS LIMITED | Director/Miembro de la Junta | 16/11/2012 | 01/04/2014 |
| Director Ejecutivo | 28/12/2011 | 01/04/2014 | |
| Contacto de Relaciones con Inversores | 28/12/2011 | 01/04/2014 | |
| Public Communications Contact | 28/12/2011 | 01/04/2014 | |
Galapagos Genomics NV
 Galapagos Genomics NV Pharmaceuticals: MajorHealth Technology Galapagos is a discovery company focused on the identification of disease modifying drug targets by functionally screening human disease models and the subsequent progression of these targets into drug discovery. Galapagos is a genomics based drug discovery company with programs in osteoporosis, rheumatoid arthritis, osteoarthritis, Alzheimer's disease and asthma. | Corporate Officer/Principal | - | 02/05/2008 |
Diatranz Otsuka Ltd.
 Diatranz Otsuka Ltd. Pharmaceuticals: MajorHealth Technology Diatranz Otsuka Ltd. manufactures pharmaceutical products. Its product, DIABECELL, is used to treat type1 diabetes. The company was founded on November 11, 2011 and is headquartered in Auckland, New Zealand. | Director Ejecutivo | 01/04/2014 | - |
Formación de Andrea Grant.
| University of Cambridge | Doctorate Degree |
Estadísticas
Internacional
| Nueva Zelanda | 3 |
| Bélgica | 2 |
| Reino Unido | 2 |
Operativa
| Chief Executive Officer | 2 |
| Corporate Officer/Principal | 1 |
| Director/Board Member | 1 |
Sectorial
| Health Technology | 4 |
| Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| ALGORAE PHARMACEUTICALS LIMITED | Health Technology |
| Empresas privadas | 2 |
|---|---|
Galapagos Genomics NV
Galapagos Genomics NV Pharmaceuticals: MajorHealth Technology Galapagos is a discovery company focused on the identification of disease modifying drug targets by functionally screening human disease models and the subsequent progression of these targets into drug discovery. Galapagos is a genomics based drug discovery company with programs in osteoporosis, rheumatoid arthritis, osteoarthritis, Alzheimer's disease and asthma. | Health Technology |
Diatranz Otsuka Ltd.
Diatranz Otsuka Ltd. Pharmaceuticals: MajorHealth Technology Diatranz Otsuka Ltd. manufactures pharmaceutical products. Its product, DIABECELL, is used to treat type1 diabetes. The company was founded on November 11, 2011 and is headquartered in Auckland, New Zealand. | Health Technology |
- Bolsa de valores
- Insiders
- Andrea Grant
- Experiencia
